Krystal Biotech Inc
NASDAQ:KRYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
A
|
Amazon.com Inc
SGO:AMZN
|
US |
|
Tencent Music Entertainment Group
F:63T
|
CN |
|
Investec PLC
LSE:INVP
|
UK |
|
A
|
Apex Critical Metals Corp
CNSX:APXC
|
CA |
|
Deutsche Bank AG
NYSE:DB
|
DE |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
Wall St Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for KRYS is 344.45 USD with a low forecast of 217.15 USD and a high forecast of 423.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KRYS's stock price target?
Price Target
344.45
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 344.45 USD with a low forecast of 217.15 USD and a high forecast of 423.15 USD.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
